Neurobehavioral Manifestations

40 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Nervous System Diseases

Narrower: Agnosia 7, Anhedonia 3, Aphasia 4, Aphasia, Broca 1, Aphasia, Primary Progressive 1, Down Syndrome 5, Dysarthria 2, Hallucinations 1, Language Disorders 9, Lethargy 4, Mania 3, Memory Disorders 1, Persistent Vegetative State 2, Phantom Limb 1, Psychomotor Agitation 1, Speech Disorders 7

Treatments and conditions

Neurobehavioral Manifestations
Treatment and conditionWhere it standsTrials
ACP-204 for hallucinationsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Acupuncture for agnosiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aticaprant for anhedoniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Baclofen for psychomotor agitationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
BrainGate Neural Interface System for aphasiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BrainGate Neural Interface System for aphasia, brocaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BrainGate Neural Interface System for dysarthriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Buprenorphine hydrochloride for agnosiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Chronic speech BCI for speech disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Communication Bridge™ for aphasia, primary progressivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Depression Cognitive Training + tDCS (active stimulation) for neurobehavioral manifestationsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Depression Cognitive Training + tDCS (sham stimulation) for neurobehavioral manifestationsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Divalproex sodium for maniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab for down syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Escitalopram oxalate for aphasiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Escitalopram oxalate for lethargyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
FLUOROETHOXYBENZOVESAMICOL F-18 for down syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine for down syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
IM ketamine in dose finding and then continuation for phantom limbPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
intermittent theta burst stimulation (iTBS) for lethargyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
intermittent theta burst stimulation (iTBS) + METHYLPHENIDATE HYDROCHLORIDE for lethargyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketoprofen for agnosiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Laboratory Biomarker Analysis + CYTARABINE + ASPARAGINASE ERWINIA CHRYSANTHEMI + ASPARAGINASE + Mitoxantrone Hydrochloride for down syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Laboratory Biomarker Analysis + CYTARABINE + ETOPOSIDE + THIOGUANINE + Daunorubicin Hydrochloride for down syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Leucovorin for language disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Levoleucovorin calcium for language disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Lithium for maniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active) for lethargyPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
MRI + Psilocybin + Risperidone for anhedoniaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
N1 Implant + R1 Robot for dysarthriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Non-Specific Cognitive Training + tDCS (sham stimulation) for neurobehavioral manifestationsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for agnosiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for anhedoniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®) with the Magnus Neuromodulation System for memory disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
stimulation device for persistent vegetative stateTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Suzetrigine for agnosiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
the Terumo Hydropearl® microspheres device for agnosiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vagus nerve stimulation; for persistent vegetative stateTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Valproic acid for maniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vasopressin for agnosiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.